Showing 3961-3970 of 20452 results for "".
- Emerging Innovations in Dry Eye Treatment: Understanding the Role of Tryptyrhttps://reachmd.com/news/emerging-innovations-in-dry-eye-treatment-understanding-the-role-of-tryptyr/2475989/With the US launch of Tryptyr by Alcon, clinicians have a new TRPM8 receptor agonist that targets tear production. Dry eye disease persists as a widesp
- Evolving Strategies in Alzheimer's and Stroke Recovery: New Insights and Innovationshttps://reachmd.com/news/evolving-strategies-in-alzheimers-and-stroke-recovery-new-insights-and-innovations/2475994/Leqembi’s demonstration of slowed cognitive decline in early Alzheimer’s disease represents a paradigm shift in addressing an unmet need for disease-modifying therapies, as shown in the
- Opioid-Sparing Strategies Improve Post-Surgical Outcomes in Orthopedicshttps://reachmd.com/news/opioid-sparing-strategies-improve-post-surgical-outcomes-in-orthopedics/2475963/Opioid-sparing strategies offer significant benefits in post-surgical pain management, especially in orthopedic procedures, as demonstrated by real-world data in orthopedic surgery a
- Innovative Strategies in Antibiotic Resistance: Expanding the Role of Photodynamic Therapyhttps://reachmd.com/news/innovative-strategies-in-antibiotic-resistance-expanding-the-role-of-photodynamic-therapy/2475935/Antibiotic resistance is escalating worldwide, with multidrug-resistant Klebsiella pneumoniae presenting an urgent challenge that threatens to outpace current therapies — photodynamic therapy (PDT) emerges from preclinical studies as a novel adjunct to potentially restore antibioti
- Innovations in EMR Usage for Early HAE Diagnosis and SLOS Managementhttps://reachmd.com/news/innovations-in-emr-usage-for-early-hae-diagnosis-and-slos-management/2475905/Emerging diagnostic techniques utilizing Electronic Medical Records (EMRs) are enhancing early detection of Hereditary Angioedema (HAE), aligning with the WAO/EAACI guidelines that emphasize the
- Navigating Social Media’s Growing Influence in Cosmetic Dermatology: Strategies for Today’s Practicehttps://reachmd.com/news/navigating-social-medias-growing-influence-in-cosmetic-dermatology-strategies-for-todays-practice/2475926/Social media is rapidly reshaping patient behaviors in cosmetic dermatology and challenging clinicians to keep pace as platforms and perceptions evolve at breakneck speed. Dermatologists now confront a landscape where patient decisions about fillers, neuromodulators and energy-based
- Evolving Role of Frequent Flares in Atopic Dermatitis: Predicting Severity and Impact on Quality of Lifehttps://reachmd.com/news/evolving-role-of-frequent-flares-in-atopic-dermatitis-predicting-severity-and-impact-on-quality-of-life/2475837/A recent study on AD flares as prognostic markers reveals that frequent atopic dermatitis flares forecast markedly higher
- Innovative Advances in COPD: Biologic Therapies and Gender-Specific Riskshttps://reachmd.com/news/innovative-advances-in-copd-biologic-therapies-and-gender-specific-risks/2475874/Recent developments in COPD management unveil the potential of targeted biologic therapy to substantially reduce exacerbations while highlighting that women may carry a disproportionate disease burden even in the absence of traditional risk factors. For decades, pulmonologists have grapple
- Innovative Strategies Reshaping Breast Cancer Treatment: Emerging Therapies and Clinical Implicationshttps://reachmd.com/news/innovative-strategies-reshaping-breast-cancer-treatment-emerging-therapies-and-clinical-implications/2475856/Breast cancer treatment is undergoing a revolution as cutting-edge approaches such as powerlifting strategies, dual-action therapies, and targeted molecular degraders open new clinical pathways for patient care. Oncologists have long grappled with balancing treatment efficacy against
- Subclinical Synovitis Risk Higher in Psoriasis Without Musculoskeletal Involvementhttps://reachmd.com/news/subclinical-synovitis-risk-higher-in-psoriasis-without-musculoskeletal-involvement/2475832/A recent analysis reveals that subclinical synovitis is 2.5-fold more common in psoriasis patients without overt musculoskeletal symptoms than in healthy control